Violation Tracker Individual Record
Date:May 7, 2020
Offense Group:competition-related offenses
Primary Offense:price-fixing or anti-competitive practices
Apotex Corp., a generic pharmaceutical company headquartered in Florida, agreed to pay a criminal penalty of $24.1 million under a deferred prosecution agreement relating to fixing the price of the generic drug pravastatin.
Level of Government:federal
Action Type:agency action
Agency:Justice Department Antitrust Division
Civil or Criminal Case:criminal
Prosecution Agreement:deferred prosecution agreement
Source Notes:If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.